Correction: Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1

Daniel D Buchanan^{1

2

3}, Jenna R Stewart⁴, Mark Clendenning⁴, Christophe Rosty^{4

5

6}, Khalid Mahmood^{4

7}, Bernard J Pope^{4

7}, Mark A Jenkins⁸, John L Hopper⁸, Melissa C Southey⁹, Finlay A Macrae^{10

11

12}, Ingrid M Winship^{10

11}, Aung Ko Win^{8

10}

Affiliations

¹ Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia. daniel.buchanan@unimelb.edu.au.
² Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia. daniel.buchanan@unimelb.edu.au.
³ Genetic Medicine and Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia. daniel.buchanan@unimelb.edu.au.
⁴ Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.
⁵ Envoi Specialist Pathologists, Herston, Queensland, Australia.
⁶ School of Medicine, University of Queensland, Herston, Queensland, Australia.
⁷ Melbourne Bioinformatics, The University of Melbourne, Carlton, Victoria, Australia.
⁸ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
⁹ Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.
¹⁰ Genetic Medicine and Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
¹¹ Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.
¹² Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

Free article

Published Erratum

Daniel D Buchanan et al. Genet Med. 2018 Oct.

Free article

. 2018 Oct;20(10):1299.

doi: 10.1038/gim.2017.265.

¹ Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia. daniel.buchanan@unimelb.edu.au.
² Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia. daniel.buchanan@unimelb.edu.au.
³ Genetic Medicine and Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia. daniel.buchanan@unimelb.edu.au.
⁴ Colorectal Oncogenomics Group, Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.
⁵ Envoi Specialist Pathologists, Herston, Queensland, Australia.
⁶ School of Medicine, University of Queensland, Herston, Queensland, Australia.
⁷ Melbourne Bioinformatics, The University of Melbourne, Carlton, Victoria, Australia.
⁸ Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Parkville, Victoria, Australia.
⁹ Genetic Epidemiology Laboratory, Department of Pathology, The University of Melbourne, Parkville, Victoria, Australia.
¹⁰ Genetic Medicine and Familial Cancer Centre, The Royal Melbourne Hospital, Parkville, Victoria, Australia.
¹¹ Department of Medicine, The University of Melbourne, Parkville, Victoria, Australia.
¹² Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Parkville, Victoria, Australia.

Abstract

The abstract to this article contained errors in the Results and Conclusions section. The corrected sections are shown below.

Risk of colorectal cancer for carriers of a germ-line mutation in POLE or POLD1.
Buchanan DD, Stewart JR, Clendenning M, Rosty C, Mahmood K, Pope BJ, Jenkins MA, Hopper JL, Southey MC, Macrae FA, Winship IM, Win AK. Buchanan DD, et al. Genet Med. 2018 Aug;20(8):890-895. doi: 10.1038/gim.2017.185. Epub 2017 Nov 9. Genet Med. 2018. PMID: 29120461 Free PMC article.